Oncodesign Precision Medicine Société anonyme (EPA:ALOPM)
France · Delayed Price · Currency is EUR 0.4990
-0.0010 (-0.20%)
At close: Feb 20, 2026
EPA:ALOPM Market Cap
EPA:ALOPM has a market cap or net worth of €9.04 million as of February 20, 2026. Its market cap has decreased by -0.45% in one year.
Market Cap
9.04M
Enterprise Value
13.12M
Revenue
1.74M
Ranking
n/a
PE Ratio
1.44
Stock Price
€0.50
Market Cap Chart
Since October 5, 2022, EPA:ALOPM's market cap has increased from 5.82M to 9.04M, an increase of 55.28%. That is a compound annual growth rate of 13.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 9.04M | 21.12% |
| Dec 31, 2025 | 7.47M | -42.44% |
| Dec 31, 2024 | 12.97M | -56.74% |
| Dec 29, 2023 | 29.99M | 155.14% |
| Dec 30, 2022 | 11.75M | 101.80% |
| Oct 5, 2022 | 5.82M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nicox | 34.72M |
| Advicenne | 30.96M |
| genOway Société anonyme | 22.31M |
| Aelis Farma | 18.83M |
| GenSight Biologics | 18.06M |
| Poxel | 14.70M |
| NFL Biosciences | 13.71M |
| Plant Advanced Technologies | 9.36M |